-
1
-
-
38849152398
-
Targeted therapies: A new generation of cancer treatments
-
Gerber DE:, Targeted therapies: A new generation of cancer treatments. Am Fam Physician 2008; 77: 311-319. (Pubitemid 351206593)
-
(2008)
American Family Physician
, vol.77
, Issue.3
, pp. 311-319
-
-
Gerber, D.E.1
-
2
-
-
35648993429
-
Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies
-
Viale G:, Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies. Breast 2007; 16: S55-S58.
-
(2007)
Breast
, vol.16
-
-
Viale, G.1
-
3
-
-
36849069347
-
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
DOI 10.1200/JCO.2007.14.2364
-
Harris L, Fritsche H, Mennel R, et al.: American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007; 25: 5287-5312. (Pubitemid 350232263)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.33
, pp. 5287-5312
-
-
Harris, L.1
Fritsche, H.2
Mennel, R.3
Norton, L.4
Ravdin, P.5
Taube, S.6
Somerfield, M.R.7
Hayes, D.F.8
Bast Jr., R.C.9
-
4
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
DOI 10.1073/pnas.191367098
-
SÃrlie T, Perou CM, Tibshirani R, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874. (Pubitemid 32878711)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.19
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshirani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
Van De Rijn, M.9
Jeffrey, S.S.10
Thorsen, T.11
Quist, H.12
Matese, J.C.13
Brown, P.O.14
Botstein, D.15
Lonning, P.E.16
Borresen-Dale, A.-L.17
-
5
-
-
0019850184
-
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
-
Liotta LA, Goldfarb RH, Brundage R, et al.: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629-4636. (Pubitemid 12201384)
-
(1981)
Cancer Research
, vol.41
, Issue.11
, pp. 4629-4636
-
-
Liotta, L.A.1
Goldfarb, R.H.2
Brundage, R.3
-
6
-
-
0033968403
-
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
-
Foekens JA, Peters HA, Look MP, et al.: The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res 2000; 60: 636-643. (Pubitemid 30094561)
-
(2000)
Cancer Research
, vol.60
, Issue.3
, pp. 636-643
-
-
Foekens, J.A.1
Peters, H.A.2
Look, M.P.3
Portengen, H.4
Schmitt, M.5
Kramer, M.D.6
Brunner, N.7
Janicke, F.8
Meijer-Van Gelder, M.E.9
Henzen-Logmans, S.C.10
Van Putten, W.L.J.11
Klijn, J.G.M.12
-
7
-
-
15544384612
-
Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
-
Nomura T, Katunuma N:, Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9.
-
(2005)
J Med Invest
, vol.52
, pp. 1-9
-
-
Nomura, T.1
Katunuma, N.2
-
8
-
-
0034634751
-
Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas
-
Greco S, Marsigliante S, Leo G, et al.: Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas. Cancer Lett 2000; 160: 13-19.
-
(2000)
Cancer Lett
, vol.160
, pp. 13-19
-
-
Greco, S.1
Marsigliante, S.2
Leo, G.3
-
10
-
-
0034802806
-
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and Cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy
-
Harbeck N, Alt U, Berger U, et al.: Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res 2001; 7: 2757-2764. (Pubitemid 32911381)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.9
, pp. 2757-2764
-
-
Harbeck, N.1
Alt, U.2
Berger, U.3
Kruger, A.4
Thomssen, C.5
Janicke, F.6
Hofler, H.7
Kates, R.E.8
Schmitt, M.9
-
11
-
-
0037116616
-
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients
-
Look MP, van Putten WL, Duffy MJ, et al.: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 2002; 94: 116-128. (Pubitemid 34121291)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.2
, pp. 116-128
-
-
Look, M.P.1
Van Putten, W.L.J.2
Duffy, M.J.3
Harbeck, N.4
Christensen, I.J.5
Thomssen, C.6
Kates, R.7
Spyratos, F.8
Ferno, M.9
Eppenberger-Castori, S.10
Sweep, C.G.J.F.11
Ulm, K.12
Peyrat, J.-P.13
Martin, P.-M.14
Magdelenat, H.15
Brunner, N.16
Duggan, C.17
Lisboa, B.W.18
Bendahl, P.-O.19
Quillien, V.20
Daver, A.21
Ricolleau, G.22
Meijer-Van Gelder, M.E.23
Manders, P.24
Fiets, W.E.25
Blankenstein, M.A.26
Broet, P.27
Romain, S.28
Daxenbichler, G.29
Windbichler, G.30
Cufer, T.31
Borstnar, S.32
Kueng, W.33
Beex, L.V.A.M.34
Klijn, J.G.M.35
O'Higgins, N.36
Eppenberger, U.37
Janicke, F.38
Schmitt, M.39
Foekens, J.A.40
more..
-
12
-
-
0026779790
-
Multiparametric prognostic evaluation of biological factors in primary breast cancer
-
Spyratos F, Martin PM, HacÃne K, et al.: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 1992; 84: 1266-1272.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1266-1272
-
-
Spyratos, F.1
Martin, P.M.2
Hacãne, K.3
-
13
-
-
0029865319
-
A computer program to assist in making breast cancer adjuvant therapy decisions
-
Ravdin PM:, A computer program to assist in making breast cancer adjuvant therapy decisions. Semin Oncol 1996; 23: 43-50. (Pubitemid 26105769)
-
(1996)
Seminars in Oncology
, vol.23
, Issue.1 SUPPL. 2
, pp. 43-50
-
-
Ravdin, P.M.1
-
14
-
-
0035865149
-
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
-
Ravdin PM, Siminoff LA, Davis GJ, et al.: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001; 19: 980-991. (Pubitemid 32176272)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.4
, pp. 980-991
-
-
Ravdin, P.M.1
Siminoff, L.A.2
Davis, G.J.3
Mercer, M.B.4
Hewlett, J.5
Gerson, N.6
Parker, H.L.7
-
15
-
-
50849143820
-
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers
-
Shariat SF, Karam JA, Walz J, et al.: Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin Cancer Res 2008; 14: 3785-3791.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3785-3791
-
-
Shariat, S.F.1
Karam, J.A.2
Walz, J.3
-
16
-
-
33644663354
-
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
-
Rouzier R, Pusztai L, Delaloge S, et al.: Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol 2005; 23: 8331-8339.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8331-8339
-
-
Rouzier, R.1
Pusztai, L.2
Delaloge, S.3
-
17
-
-
67649959162
-
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study
-
Coutant C, Olivier C, Lambaudie E, et al.: Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study. J Clin Oncol 2009; 27: 2800-2808.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2800-2808
-
-
Coutant, C.1
Olivier, C.2
Lambaudie, E.3
-
18
-
-
67349278848
-
A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis
-
Houvenaeghel G, Nos C, Giard S, et al.: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009; 35: 690-695.
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 690-695
-
-
Houvenaeghel, G.1
Nos, C.2
Giard, S.3
-
19
-
-
0028838106
-
Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy
-
Bonnier P, Romain S, Giacalone PL, et al.: Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995; 85: 11-17.
-
(1995)
Obstet Gynecol
, vol.85
, pp. 11-17
-
-
Bonnier, P.1
Romain, S.2
Giacalone, P.L.3
-
20
-
-
0028148124
-
Biological heterogeneity of ER-positive breast cancers in the post-menopausal population
-
DOI 10.1002/ijc.2910590105
-
Romain S, Chinot O, Guirou O, et al.: Biological heterogeneity of ER-positive breast cancers in the post-menopausal population. Int J Cancer 1994; 59: 17-19. (Pubitemid 24310941)
-
(1994)
International Journal of Cancer
, vol.59
, Issue.1
, pp. 17-19
-
-
Romain, S.1
Chinot, O.2
Guirou, O.3
Soulliere, M.4
Martin, P.-M.5
-
21
-
-
0022531756
-
Standardization of steroid receptor assays in human breast cancer. IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays
-
DOI 10.1016/0277-5379(86)90061-1
-
Koenders A, Thorpe SM:, Standardization of steroid receptor assays in human breast cancer - IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol 1986; 22: 945-952. (Pubitemid 16035146)
-
(1986)
European Journal of Cancer and Clinical Oncology
, vol.22
, Issue.8
, pp. 945-952
-
-
Koenders, A.1
Thorpe, S.M.2
-
22
-
-
0032919675
-
Cathepsin-D in primary breast cancer: Prognostic evaluation involving 2810 patients
-
Foekens JA, Look MP, Bolt-de Vries J, et al.: Cathepsin-D in primary breast cancer: Prognostic evaluation involving 2810 patients. Br J Cancer 1999; 79: 300-307. (Pubitemid 29002300)
-
(1999)
British Journal of Cancer
, vol.79
, Issue.2
, pp. 300-307
-
-
Foekens, J.A.1
Look, M.P.2
Bolt-De Vries, J.3
Meijer-Van Gelder, M.E.4
Van Putten, W.L.J.5
Klijn, J.G.M.6
-
23
-
-
0024436155
-
Cathepsin D: An independent prognostic factor for metastasis breast cancer
-
Spyratos F, Maudelonde T, Brouillet JP, et al.: Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 1989; 2: 1115-1118. (Pubitemid 19268738)
-
(1989)
Lancet
, vol.2
, Issue.8672
, pp. 1115-1118
-
-
Spyratos, F.1
Maudelonde, T.2
Brouillet, J.-P.3
Brunet, M.4
Defrenne, A.5
Andrieu, C.6
Hacene, K.7
Desplaces, A.8
Rouesse, J.9
Rochefort, H.10
-
24
-
-
0031031582
-
Tumor-related prognostic factors for breast cancer
-
Donegan WL:, Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997; 47: 28-51. (Pubitemid 27050848)
-
(1997)
Ca-A Cancer Journal for Clinicians
, vol.47
, Issue.1
, pp. 28-51
-
-
Donegan, W.L.1
-
25
-
-
0028905086
-
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer
-
Romain S, Christensen IJ, Chinot O, et al.: Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. Int J Cancer 1995; 61: 7-12.
-
(1995)
Int J Cancer
, vol.61
, pp. 7-12
-
-
Romain, S.1
Christensen, I.J.2
Chinot, O.3
-
26
-
-
67650382242
-
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer
-
Colleoni M, Bagnardi V, Rotmensz N, et al.: A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. Ann Oncol 2009; 20: 1178-1184.
-
(2009)
Ann Oncol
, vol.20
, pp. 1178-1184
-
-
Colleoni, M.1
Bagnardi, V.2
Rotmensz, N.3
-
27
-
-
65349171945
-
A prediction model for breast cancer recurrence after adjuvant hormone therapy
-
Boracchi P, Coradini D, Antolini S, et al.: A prediction model for breast cancer recurrence after adjuvant hormone therapy. Int J Biol Markers 2008; 23: 199-206.
-
(2008)
Int J Biol Markers
, vol.23
, pp. 199-206
-
-
Boracchi, P.1
Coradini, D.2
Antolini, S.3
-
28
-
-
36849011103
-
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma
-
DOI 10.1200/JCO.2006.08.0499
-
Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al.: Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 2007; 25: 4952-4960. (Pubitemid 350220427)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.31
, pp. 4952-4960
-
-
Hanrahan, E.O.1
Gonzalez-Angulo, A.M.2
Giordano, S.H.3
Rouzier, R.4
Broglio, K.R.5
Hortobagyi, G.N.6
Valero, V.7
-
29
-
-
41149119907
-
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy
-
Shariat SF, Walz J, Roehrborn CG, et al.: External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 2008; 26: 1526-1531.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1526-1531
-
-
Shariat, S.F.1
Walz, J.2
Roehrborn, C.G.3
|